Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

4(57.1%)

Phase 1

3(42.9%)

7Total

N/A(4)

Phase 1(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT06443242Not ApplicableNot Yet Recruiting

Efficacy and Safety of Low-dose Laser Acupuncture on Treating Insomnia Associated With Major Depressive Disorder

Role: collaborator

NCT04800419Not ApplicableCompleted

RCT of Effects of Mindfulness-based Stress Reduction in Head and Neck Cancer

Role: collaborator

NCT05528341Phase 1Recruiting

NKG2D-CAR-NK92 Cells Immunotherapy for Solid Tumors

Role: lead

NCT06612216Not Yet Recruiting

Establishment of Cohort Under the Guidance of the Pathogenesis of Cancer Toxin in Traditional Chinese Medicine

Role: collaborator

NCT04280224Phase 1Completed

NK Cells Treatment for COVID-19

Role: lead

NCT03656705Phase 1Completed

CCCR-NK92 Cells Immunotherapy for Non-small Cell Lung Carcinoma

Role: lead

NCT05841823Not ApplicableNot Yet Recruiting

Virtual Reality Exposure Therapy in the Treatment of Alcohol Use Disorder

Role: collaborator

NCT05830708Not ApplicableNot Yet Recruiting

The Efficacy of Probiotics for the Treatment of Alcohol Use Disorder Among Adult Males

Role: collaborator

All 8 trials loaded